These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3515694)

  • 1. Cyclosporine therapy independent of graft diuresis in cadaveric renal transplants.
    Taylor RJ; Zheng S; Ptachinski R; Rosenthal JT; Hakala TR
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):5-7. PubMed ID: 3515694
    [No Abstract]   [Full Text] [Related]  

  • 2. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.
    Simmons RL; Canafax DM; Fryd DS; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):76-81. PubMed ID: 3008390
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Japanese trial of cyclosporine in living related and cadaveric renal transplantation.
    Ochiai T; Toma H; Oka T; Takagi H; Kashiwabara H; Ishibashi M; Fukao K; Ota K; Hashimoto I; Sonoda T
    Transplant Proc; 1985 Aug; 17(4):2035-40. PubMed ID: 3895651
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of low-dose cyclosporine A on histopathologic findings in transplant biopsy specimens and function rates after cadaver renal transplantation.
    Niebel W; Metz K; Donhuijsen D; Albrecht KH; Windeck R; Eigler FW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1772-5. PubMed ID: 3547882
    [No Abstract]   [Full Text] [Related]  

  • 7. Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy.
    Lundgren G; Fehrman I; Gunnarsson R; Lindholm B; Tillegård A; Ost L; Groth CG
    Transplant Proc; 1982 Sep; 14(3):601-4. PubMed ID: 6758244
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 10. Is withdrawal of steroids hazardous to cadaveric renal transplants under treatment with cyclosporine?
    Hillebrand G; Krumme D; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):126-9. PubMed ID: 3291225
    [No Abstract]   [Full Text] [Related]  

  • 11. Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.
    Mendez R; Mendez RG; Koussa N; Cats S; Bogaard TP; Khetan U
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2047-50. PubMed ID: 3547908
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of delayed function in cyclosporine-treated cadaver kidney transplants.
    Belitsky P; MacDonald AS; Gajewski J; Boudreau J; Bitter-Suermann H; Cohen A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2096-9. PubMed ID: 3547912
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine use in early graft dysfunction.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants.
    Taylor RJ; Landreneau MD; Makowka L; Rosenthal TJ; Gordon RD; Tzakis AG; Starzl TE; Hakala TR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2100-3. PubMed ID: 3547913
    [No Abstract]   [Full Text] [Related]  

  • 17. The intake of initially high doses of cyclosporine A in cadaveric kidney transplantation is not justified. Results of a prospective study.
    Niebel W; Albrecht KH; Metz K; Jakubowski HD; Windeck R; Eigler FW
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):394-7. PubMed ID: 3279628
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report.
    Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):689-90. PubMed ID: 8438438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.